ArticleEuropean journal of hospital pharmacy : science and practice2021
Factors associated with a reduction in the quality of life of patients with chronic hepatitis C treated by ledipasvir/sofosbuvir therapy.
Yuka Aimono et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.